| Literature DB >> 28075062 |
Mariana Beatriz Badia1, Robert Mans2, Alicia V Lis2,3, Marcos Ariel Tronconi1, Cintia Lucía Arias1, Verónica Graciela Maurino4, Carlos Santiago Andreo1, María Fabiana Drincovich1, Antonius J A van Maris2,5, Mariel Claudia Gerrard Wheeler1.
Abstract
NAD(P)-malic enzyme (NAD(P)-ME) catalyzes the reversible oxidative decarboxylation of malate to pyruvate, CO2 , and NAD(P)H and is present as a multigene family in Arabidopsis thaliana. The carboxylation reaction catalyzed by purified recombinant Arabidopsis NADP-ME proteins is faster than those reported for other animal or plant isoforms. In contrast, no carboxylation activity could be detected in vitro for the NAD-dependent counterparts. In order to further investigate their putative carboxylating role in vivo, Arabidopsis NAD(P)-ME isoforms, as well as the NADP-ME2del2 (with a decreased ability to carboxylate pyruvate) and NADP-ME2R115A (lacking fumarate activation) versions, were functionally expressed in the cytosol of pyruvate carboxylase-negative (Pyc- ) Saccharomyces cerevisiae strains. The heterologous expression of NADP-ME1, NADP-ME2 (and its mutant proteins), and NADP-ME3 restored the growth of Pyc- S. cerevisiae on glucose, and this capacity was dependent on the availability of CO2 . On the other hand, NADP-ME4, NAD-ME1, and NAD-ME2 could not rescue the Pyc- strains from C4 auxotrophy. NADP-ME carboxylation activity could be measured in leaf crude extracts of knockout and overexpressing Arabidopsis lines with modified levels of NADP-ME, where this activity was correlated with the amount of NADP-ME2 transcript. These results indicate that specific A. thaliana NADP-ME isoforms are able to play an anaplerotic role in vivo and provide a basis for the study on the carboxylating activity of NADP-ME, which may contribute to the synthesis of C4 compounds and redox shuttling in plant cells.Entities:
Keywords: zzm321990Saccharomyces cerevisiaezzm321990; C4 organic acids; anaplerotic role; malate synthesis; plant metabolism
Mesh:
Substances:
Year: 2017 PMID: 28075062 DOI: 10.1111/febs.14013
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542